Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier

The Mitochondrial Pyruvate Carrier: Has It Been Unearthed at Last?

(2012) Andrew P. Halestrap   Cell Metabolism

Thiazolidinedione use and cancer incidence in type 2 diabetes: A systematic review and meta-analysis

(2012) I.N. Colmers et al.   DIABETES & METABOLISM

Insulin Resistance and Metabolic Derangements in Obese Mice Are Ameliorated by a Novel Peroxisome Proliferator-activated Receptor γ-sparing Thiazolidinedione

(2012) Zhouji Chen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A Viral Deubiquitylating Enzyme Restores Dislocation of Substrates from the Endoplasmic Reticulum (ER) in Semi-intact Cells

(2012) Sumana Sanyal et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Exercise-induced AMPK activity in skeletal muscle: Role in glucose uptake and insulin sensitivity

(2012) Martin Friedrichsen et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

A Mitochondrial Mystery, Solved

(2012) A. S. Divakaruni et al.   SCIENCE

Identification and Functional Expression of the Mitochondrial Pyruvate Carrier

(2012) S. Herzig et al.   SCIENCE

A Mitochondrial Pyruvate Carrier Required for Pyruvate Uptake in Yeast, Drosophila, and Humans

(2012) D. K. Bricker et al.   SCIENCE

Rosiglitazone and Pioglitazone for the Treatment of Alzheimer's Disease

(2011) Benjamin W Miller et al.   ANNALS OF PHARMACOTHERAPY

Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner

(2011) Yochai Birnbaum et al.   BASIC RESEARCH IN CARDIOLOGY

Preservation of β-Cell Function: The Key to Diabetes Prevention

(2011) Ralph A. DeFronzo et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pioglitazone Reduces Secondary Brain Damage after Experimental Brain Trauma by PPAR-γ-Independent Mechanisms

(2011) Serge C. Thal et al.   JOURNAL OF NEUROTRAUMA

Phospholipid Hydrolysis Caused byClostridium perfringensα-Toxin Facilitates the Targeting of Perfringolysin O to Membrane Bilayers

(2010) Paul C. Moe et al.   BIOCHEMISTRY

Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation

(2010) Simon A. Hawley et al.   Cell Metabolism

Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone

(2010) David J. Graham et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Energy Restriction as an Antitumor Target of Thiazolidinediones

(2010) Shuo Wei et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Effects of Pioglitazone on Intramyocellular Fat Metabolism in Patients with Type 2 Diabetes Mellitus

(2010) Mandeep Bajaj et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5

(2010) Jang Hyun Choi et al.   NATURE

Brain fuel metabolism, aging, and Alzheimer’s disease

(2010) Stephen Cunnane et al.   NUTRITION

Regulation of intermediary metabolism by protein acetylation

(2010) Kun-Liang Guan et al.   TRENDS IN BIOCHEMICAL SCIENCES

Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial

(2009) D. K. Coletta et al.   DIABETOLOGIA

Cardioprotective stimuli mediate phosphoinositide 3-kinase and phosphoinositide dependent kinase 1 nuclear accumulation in cardiomyocytes

(2009) Marta Rubio et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY